胆结石疾病与心血管疾病之间的关联:系统性审查和元分析
Rasoul Rahimi1, Saeid Heidari-Soureshjani2, Catherine Mt Sherwin3
1Department of Surgery, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Reviews on recent clinical trials
|October 10, 2024
概括
胆结石病 (GSD) 显著增加了心血管疾病 (CVD) 的风险. 对GSD的早期干预可能有助于预防心血管疾病,突出了这些疾病之间的关键联系.
科学领域:
- 心脏病学 心脏病学
- 胃肠病学 胃肠病学
- 流行病学 流行病学
背景情况:
- 胆结石病 (GSD) 是众所周知的多种健康并发症的风险因素.
- 了解GSD和心血管疾病 (CVD) 之间的联系对于公共健康至关重要.
研究的目的:
- 系统地审查和元分析胆结石疾病和心血管疾病之间的关联.
- 量化GSD患者心血管疾病的风险.
主要方法:
- 在主要数据库 (1980-2023) 中进行了全面的文献搜索.
- 包括21项研究,超过200万参与者.
- 统计分析包括使用 Stata 17 的异质性和出版偏差评估.
主要成果:
- 在GSD和心血管疾病风险增加之间发现了显著的关联 (RR 1.46,95% CI: 1.32-1.63).
- 没有检测到出版偏差.
- 亚组分析表明,在特定的研究群体和设计中,心血管疾病风险更高.
结论:
- 胆结石病与心血管疾病发病率的增加有显著的关联.
- 针对GSD患者的有针对性的干预措施可以减轻心血管疾病风险.
更多相关视频
相关概念视频
Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Diseases of the Liver and Gallbladder
484
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
484
Coronary Artery Disease II: Pathophysiology
3
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3
Coronary Artery Disease IV: Medical Management
4
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
4
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3


